Clinical Trials Directory

Trials / Completed

CompletedNCT05440890

Early Treatment Based Neuroscience Education in Knee

Early Treatment Based Neuroscience Education in Anterior Cruciate Ligament Repair Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
University of Malaga · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Determine the effecttiveness of a cross-education strength training protocol in a group of subjects with an anterior cruciate ligament surgery.

Detailed description

The cross-education (CE) phenomenon has been studied in recent years as a form of gain muscle strength not only in healthy subjects but also in acute injuries such as musculoskeletal disorders and immovilitations. Unilateral training of the not injured limb has been suggested as an option to produce cross-edutation in terms of strength and skills. In addition, functional magnetic resonance imaging have been postulated as a promising tool to study the mechanisms of transfer. In the context of our study, arthrogenic muscle inhibition (AMI) of knee extensors is a common consequence after ACL repair in which a CE strength training can lead to reduce quadriceps atrophy and its implications in long terms achievements. Thus, an unilateral strength protocol of the uninjuried limb, according to the last Delphi Consensus, will be run for 10 weeks to check the possible benefits of the transfer in a sample of ACL repair.

Conditions

Interventions

TypeNameDescription
OTHERBest current rehabilitation protocolInflamation control and edema with physical agents, recover full pasive and active range of motion, normalize gait pattern, lower limb strengthening (specially quadriceps and hamstrings), neuromuscular control training, cycling, landings and running.
OTHERCross-training protocolBeginning on 2º week after ACLR, 2 times per week during 10 weeks, based on isotonic exercise in leg extension and leg press.

Timeline

Start date
2025-04-01
Primary completion
2025-05-01
Completion
2026-02-01
First posted
2022-07-01
Last updated
2026-04-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05440890. Inclusion in this directory is not an endorsement.